```json
{
"content": [
{
"type": "paragraph",
"content": "Type is a critical axis in Interventional Valve segmentation, distinguishing products based on anatomical focus and procedural methodology. The two primary categories are Transcatheter Aortic Valve (TAV) and Mitral Valve Repair (MVR). TAV dominates the market due to its minimally invasive approach for treating aortic stenosis, particularly in high-risk patients, while MVR caters to the growing prevalence of mitral regurgitation. Each type contributes uniquely to market dynamics: TAV benefits from technological advancements in valve design and delivery systems, whereas MVR growth is driven by hybrid procedures and percutaneous innovations. Together, these subtypes reflect the market’s shift toward less invasive, patient-specific solutions."
},
{
"type": "paragraph",
"content": "Application within the Interventional Valve market is defined by the specific clinical indications addressed. Key subsegments include Aortic Stenosis, Mitral Regurgitation, and Other Valve Disorders (e.g., tricuspid or pulmonary). Aortic Stenosis leads in market share due to its high prevalence in aging populations and robust procedural adoption rates. Mitral Regurgitation, though smaller, is expanding rapidly due to novel device approvals and improved repair techniques. The "Other Valve Disorders" category remains niche but is gaining traction with emerging therapies. Application-based market taxonomy highlights the need for tailored solutions, with each segment influencing R&D priorities and regulatory strategies."
}
],
"chartData": {
"segments": [
{ "name": "Aortic Stenosis", "value": 55 },
{ "name": "Mitral Regurgitation", "value": 30 },
{ "name": "Other Valve Disorders", "value": 15 }
]
}
}
```
